STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Clinical trials for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy after surgery may keep lung cancer at bay
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab after surgery and chemotherapy helps prevent non-small cell lung cancer from coming back. About 900 adults with stage IB to IIIA lung cancer who had their tumor completely removed are participating. The goal is to s…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
Targeted pill may keep EGFR lung cancer from returning after surgery
Disease control OngoingThis phase 3 trial tests whether taking erlotinib (Tarceva) after surgery helps people with EGFR-mutant non-small cell lung cancer live longer and stay cancer-free longer. About 390 patients who had their lung cancer completely removed are randomly assigned to receive erlotinib p…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
Massive lung cancer study aims to match patients with targeted therapies
Knowledge-focused OngoingThis large study (ALCHEMIST) is screening over 8,000 people with early-stage non-small cell lung cancer to analyze the genes in their tumors. The goal is to identify genetic changes that could help doctors choose the best treatments, such as targeted therapies. Participants provi…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 06:00 UTC